摘要
耐甲氧西林金黄色葡萄球菌（MRSA）感染是现今医院感染控制的一大难题，目前临床常用治疗药物如万古霉素、替考拉宁存在毒性大、费用高等缺点，因此开发新型抗菌药物及治疗手段成为新的趋势，目前已有研究证实达托霉素、特地唑胺和达巴万星等药物可能具有一定的效果。本文对MRSA治疗的新型药物进行综述，以期为临床治疗提供参考。
Methicillin-resistant Staphylococcus aureus （MRSA） infection has become a challenge of the infection control in hospital. Due to the high toxicity and dispense of traditional drugs like vancomycin, teicoplanin, it becomes a trend to develop new agents such as daptomycin, tedizolid and dalbavancin. These novel drugs for the treatment of MRSA are reviewed in this article, so as to provide reference for clinical treatment.
出处
《国际流行病学传染病学杂志》
CAS
2016年第6期420-423,共4页
International Journal of Epidemiology and Infectious Disease
